Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

End In Sight For Corneal Blindness In 2030?

This article was originally published in Clinica

Executive Summary

Corneal blindness affects an estimated 28 million people around the world yet a vast majority of cases are preventable, and almost all cases treatable through corneal transplants. One non-profit organization in India, the Tej Kohli Corneal Institute (TKCI), has set itself the considerable task of ending corneal blindness globally by 2030. Tina Tan speaks to Tej Kohli, the technology entrepreneur and philanthropist that is funding this initiative, and Dr Pravin Krishna Vaddavalli, director of TKCI, to find out more about the institute’s R&D programs that will help it achieve this goal






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst